These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37315555)

  • 1. An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology.
    Sheehan PW; Nadarajah CJ; Kanan MF; Patterson JN; Novotny B; Lawrence JH; King MW; Brase L; Inman CE; Yuede CM; Lee J; Patel TK; Harari O; Benitez BA; Davis AA; Musiek ES
    Neuron; 2023 Aug; 111(15):2383-2398.e7. PubMed ID: 37315555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing matters: A protective role of astrocyte reactivity in neurodegeneration.
    Rojo D; Gibson EM
    Neuron; 2023 Aug; 111(15):2277-2279. PubMed ID: 37536287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden.
    McKee CA; Lee J; Cai Y; Saito T; Saido T; Musiek ES
    Sci Rep; 2022 Feb; 12(1):1796. PubMed ID: 35110643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
    Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
    Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
    Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: BAG3 as a Mediator of Endosome Function and Tau Clearance.
    Lin H; Deaton CA; Johnson GVW
    Neuroscience; 2023 May; 518():4-9. PubMed ID: 35550160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deposition of Phosphorylated α-Synuclein and Activation of GSK-3β and PP2A in the PS19 Mouse Model of Tauopathy.
    Takaichi Y; Chambers JK; Ano Y; Takashima A; Nakayama H; Uchida K
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):731-740. PubMed ID: 34151989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology.
    Cousins KAQ; Arezoumandan S; Shellikeri S; Ohm D; Shaw LM; Grossman M; Wolk D; McMillan CT; Chen-Plotkin A; Lee E; Trojanowski JQ; Zetterberg H; Blennow K; Irwin DJ
    Neurology; 2022 Nov; 99(20):e2303-e2312. PubMed ID: 36041863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.
    Chouhan AK; Guo C; Hsieh YC; Ye H; Senturk M; Zuo Z; Li Y; Chatterjee S; Botas J; Jackson GR; Bellen HJ; Shulman JM
    Acta Neuropathol Commun; 2016 Jun; 4(1):62. PubMed ID: 27338814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics.
    Noguchi-Shinohara M; Ono K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Autonomous Regulation of Astrocyte Activation by the Circadian Clock Protein BMAL1.
    Lananna BV; Nadarajah CJ; Izumo M; Cedeño MR; Xiong DD; Dimitry J; Tso CF; McKee CA; Griffin P; Sheehan PW; Haspel JA; Barres BA; Liddelow SA; Takahashi JS; Karatsoreos IN; Musiek ES
    Cell Rep; 2018 Oct; 25(1):1-9.e5. PubMed ID: 30282019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.
    Permanne B; Sand A; Ousson S; Nény M; Hantson J; Schubert R; Wiessner C; Quattropani A; Beher D
    ACS Chem Neurosci; 2022 Apr; 13(8):1296-1314. PubMed ID: 35357812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
    Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
    J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase.
    Takahashi H; Bhagwagar S; Nies SH; Ye H; Han X; Chiasseu MT; Wang G; Mackenzie IR; Strittmatter SM
    Nat Commun; 2024 Feb; 15(1):1434. PubMed ID: 38365772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAG3 facilitates the clearance of endogenous tau in primary neurons.
    Lei Z; Brizzee C; Johnson GV
    Neurobiol Aging; 2015 Jan; 36(1):241-8. PubMed ID: 25212465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of BAG3 in regulating SNCA/α-synuclein clearance via selective macroautophagy.
    Cao YL; Yang YP; Mao CJ; Zhang XQ; Wang CT; Yang J; Lv DJ; Wang F; Hu LF; Liu CF
    Neurobiol Aging; 2017 Dec; 60():104-115. PubMed ID: 28941726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
    Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
    Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.